Search

everythinglearnresearchcommunity

for

Search:↓

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Herbal drugs show promise for treating alopecia with fewer side effects, but standardization is challenging.

Flutamide and its metabolite can effectively reduce androgen effects.

A new treatment using cell secretions can regrow hair better than minoxidil.

Combining rosemary oil with light therapy may improve hair loss treatment.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Injecting a person's own fat into their scalp may help regrow hair and improve hair thickness in different types of hair loss.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

The document concludes that alopecia has various forms, each with specific treatments, but no definitive cure for certain types like CCCA has been proven.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Anti-aging treatments like hair transplants, minoxidil, and finasteride effectively promote hair growth.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

FAPD in children may not depend on androgens and should be treated with anti-inflammatory measures and minoxidil.

Sunflower oil was found to promote hair growth in mice with hormone-induced hair loss.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

A botanical extract may help manage hair loss from chemotherapy by preventing cell death in hair follicles.

A botanical extract was found to be a safe treatment that may prevent hair loss in chemotherapy patients.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Hormonal imbalances may play a role in frontal fibrosing alopecia, and antiandrogenic drugs combined with steroids are currently the most effective treatment.

Most men with Frontal fibrosing alopecia also lose facial hair and the condition may be linked to hormone levels and sunscreen use.

Smoking doesn't cause or prevent Frontal Fibrosing Alopecia, hormonal imbalance may be involved, and a combination of antiandrogens and steroids can help stabilize the condition.

Frontal fibrosing alopecia may be caused by an autoimmune reaction and hormonal imbalance.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

A man's baldness improved possibly due to a medication that blocks male hormones.

Rosemary shows promise in treating alopecia, similar to minoxidil, but more research is needed.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

High AMH levels are linked to PCOS in women and may have a male equivalent with similar traits.